An Open-Label Study to Evaluate the Efficacy and Safety of study drug for the Treatment of Subjects with Thrombocytopenia Scheduled for a Surgical Procedure

March 16, 2018
https://clinicaltrials.gov/ct2/show/NCT03326843
Hematology Non Malignant
Principal Investigator: Philip Kuriakose, MD
Hematology, Non malignant, Thrombocytopenia, Avatrombopag
Accepting Participants